---
figid: PMC5554756__nihms888150f2
figtitle: Negative regulators of the RIG-I-like receptor signaling pathway
organisms:
- Influenza A virus
- unidentified influenza virus
- Respiratory syncytial virus
- H1N1 subtype
- Vesicular stomatitis virus
- Encephalomyocarditis virus
- H3N2 subtype
- Homo sapiens
- Mus musculus
- Cerobasis alpha
- NA
- NA
- NA
pmcid: PMC5554756
filename: nihms888150f2.jpg
figlink: /pmc/articles/PMC5554756/figure/F2/
number: F2
caption: Negative regulators act at multiple points along the RLR signaling pathway
  to inhibit activation of RIG-I and MDA5, or to prevent their interaction with MAVS.
  ARL16, ARL5B, and possibly LGP2 prevent RIG-I and MDA5 from recognizing and binding
  RNA ligands. A20, NOD2, and LGP2 may inhibit initial activation of RIG-I, whereas
  TRIM13 and TRIM59 may inhibit MDA5 activation. FAT10 stops activated RIG-I from
  translocating to MAVS, and Atg5-Atg12, SEC14L1, and USP15 all prevent proper CARD-CARD
  interaction between RIG-I and MAVS. De-ubiquitinating enzymes, such as USP15, USP3,
  USP25, and USP21, remove the K63-linked polyubiquitin chains required for RIG-I
  and MDA5 activation, thus de-activating the RLRs. In contrast, E3 ubiquitin ligases,
  such as RNF125, RNF122, and c-Cbl K48-ubiquitinate RIG-I and MDA5, targeting them
  for degradation by the proteasome.
papertitle: Negative regulators of the RIG-I-like receptor signaling pathway.
reftext: Kendra M. Quicke, et al. Eur J Immunol. ;47(4):615-628.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9445587
figid_alias: PMC5554756__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC5554756__F2
ndex: 656c1ebf-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5554756__nihms888150f2.html
  '@type': Dataset
  description: Negative regulators act at multiple points along the RLR signaling
    pathway to inhibit activation of RIG-I and MDA5, or to prevent their interaction
    with MAVS. ARL16, ARL5B, and possibly LGP2 prevent RIG-I and MDA5 from recognizing
    and binding RNA ligands. A20, NOD2, and LGP2 may inhibit initial activation of
    RIG-I, whereas TRIM13 and TRIM59 may inhibit MDA5 activation. FAT10 stops activated
    RIG-I from translocating to MAVS, and Atg5-Atg12, SEC14L1, and USP15 all prevent
    proper CARD-CARD interaction between RIG-I and MAVS. De-ubiquitinating enzymes,
    such as USP15, USP3, USP25, and USP21, remove the K63-linked polyubiquitin chains
    required for RIG-I and MDA5 activation, thus de-activating the RLRs. In contrast,
    E3 ubiquitin ligases, such as RNF125, RNF122, and c-Cbl K48-ubiquitinate RIG-I
    and MDA5, targeting them for degradation by the proteasome.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARL16
  - ARL5B
  - IFIH1
  - RIGI
  - TNFAIP3
  - IGKV1-27
  - NOD2
  - HFM1
  - DHX58
  - SEC14L1
  - USP15
  - TRIM13
  - TRIM59
  - TRIM25
  - UBD
  - RNF125
  - USP3
  - USP2
  - MAVS
  - RNF122
  - USP25
  - CBL
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - RPS15
  - DKK3
  - DIRAS1
  - Arl16
  - Arl5b
  - Ifih1
  - Rigi
  - Tnfaip3
  - Nod2
  - Dhx58
  - Sec14l1
  - Usp15
  - Trim13
  - Trim59
  - Trim25
  - Ubd
  - Rnf125
  - Usp3
  - Usp2
  - Mavs
  - Rnf122
  - Usp25
  - Cbl
  - Rps15
  - Diras1
---
